On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Home > Archives for June 2022 > Page 24

Month: June 2022

WednesdayJun 01, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Offering Financial Savings and Energy Efficiency Across the Commercial Sector

Corporate issuers are spending over $675,000 annually on climate-related disclosures Institutional investors, on the other hand, spend about $1.4 million to collect, analyze and report climate data Correlate Infrastructure Partners Inc. seeks to offer deep financial savings and energy efficiency by reducing site-specific energy consumption and deploying clean energy generation Through its offering, it aims to help companies and investors cut down on costs associated with climate-related disclosures while also helping them adhere to the new rules and guidelines Companies worldwide are facing increasing pressure to provide climate-related disclosures. Regulators have been at the forefront of demanding these releases in…

Continue Reading

WednesdayJun 01, 2022 9:45 am

Kronos Advanced Technologies Inc. (KNOS) Committed to Providing Best Protection, Best Technology Amid Lingering Pandemic

WHO director-general warns COVID-19 is “most certainly not over” KNOS building reputation for effective, advanced, state-of-the-art air filtration and purification systems Company also offers Kronos(R)-designed graphene N95 face masks made in U.S. at NIOSH-certified facility While mask mandates have been lifted and life appears to be returning to normal in many places around the world, the COVID-19 pandemic is “most certainly not over,” reported Tedros Adhanom Ghebreyesus, director-general of the World Health Organization (https://ibn.fm/8YfkT). The need for continued vigilance has spurred many companies, including Kronos Advanced Technologies (OTC: KNOS), that are working to provide people with protection against the deadly…

Continue Reading

WednesdayJun 01, 2022 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Consistently Enhancing the Oral Administration of Active Pharmaceutical Ingredients

A global innovator in drug delivery platforms, Lexaria has developed a patented technology, DehydraTECH(TM) Through research, Lexaria has evidenced that DehydraTECH enhances the efficiency and speed of orally- administered fat-soluble active pharmaceutical ingredients (“APIs”) Lexaria is consistently enhancing the delivery of APIs that affect current oral formulations: speed of onset, limited absorption, and low membrane permeability Lexaria has conducted numerous ground-breaking studies, some of which open up the possibility of fast-acting oral products that avoid the lung diseases and cancers caused by inhalation of combusted molecules common in smoking Oral formulations account for approximately 90% of the global share of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

480-374-1336

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .